Immunosuppressive treatment for people with proliferative lupus nephritis
Systemic lupus erythematosus, or SLE, is an autoimmune disease that can affect any part of the body. About half the people with it develop lupus nephritis. In the June 2018 update of their Cochrane Review, David Tunnicliffe from the Centre for Kidney Research in the Children ’s Hospital at Westmead and the University of Sydney’s School of Public Health in Australia and colleagues brought together the studies that have tested a range of treatments. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - May 28, 2019 Category: General Medicine Authors: Cochrane Source Type: podcasts

Treatment for lupus nephritis
Systemic lupus erythematosus, or SLE, is an autoimmune disease that can affect any part of the body, and about half the people with it develop lupus nephritis. In a Cochrane Review that was updated in December 2012, Lorna Henderson from the University of Sydney at Westmead in Australia and colleagues, brought together the studies that have tested a range of treatments. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - April 22, 2014 Category: Journals (General) Authors: The Cochrane Collaboration Tags: Issue 10 to 12, October to December 2012 Source Type: podcasts